GTB-3650 Trike

GTB-3650 Trike · Masonic Cancer Center, University of Minnesota

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GTB-3650 Trike, covering 2025-06-29 to 2025-06-29. Get the full timeline:

Most recent: Clinical Trial Update: HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML [Phase 1]